Ranbaxy inks pact with Cipher to sell acne drug in Brazil

Ranbaxy has inked a licensing pact with Cipher Pharmaceuticals Inc to exclusively market its isotretinoin capsules, used to treat acne, in Brazil.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news